The drug acalabrutinib, FDA-approved for the treatment of several types of B cell cancers, improved the oxygenation levels and decreased molecular markers of inflammation in a majority of 19 patients hospitalized for the treatment of severe COVID-19, according to a new study by Mark Roschewski and c
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell…
This study aims to determine whether cancer drugs granted accelerated approval from the US Food and Drug Administration ultimately demonstrate clinical benefit and to evaluate…
This is not what we wanted to see.
There are more active drug shortages in the United States than ever, according to data from the American Society of Health-System Pharmacists and the University of…
This study aims to determine whether cancer drugs granted accelerated approval from the US Food and Drug Administration ultimately demonstrate clinical benefit and to evaluate…
This is not what we wanted to see.
Researchers looking for clues to why some types of cancer are on the rise in younger adults say they’ve found an interesting lead—a connection to…
There are more active drug shortages in the United States than ever, according to data from the American Society of Health-System Pharmacists and the University of…
There are at least 323 active shortages, according to a pharmacy trade group.
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
